Skip to search boxSkip to navigationSkip to main content

Two-way communication between the nucleus and mitochondria via a micropeptide in renal fibrosis

*Corresponding author for this work
Scholary Output:
Contribution to journal
Comment/debate
Peer-review

Abstract

Micropeptides are small proteins encoded by short open reading frames mostly located in long noncoding RNAs. Mitoregulin (MOXI) is a nuclear encoded micropeptide initially identified in the inner mitochondrial membrane to regulate fatty acid β-oxidation. In this issue of Kidney International, Li et al. report that MOXI is upregulated in both human fibrotic kidneys and murine models of renal fibrosis. Remarkably, MOXI functions in the nucleus, where it forms a transcriptional complex with N-acetyltransferase 14 and c-Jun to facilitate the expression of fibrotic genes. By working in the nucleus and mitochondria, MOXI may channel the 2-way communication between these organelles, adding a new layer of complexity in the cell biology of renal fibrogenesis.

Publication Information

Output type

Scholary Output:
Contribution to journal
Comment/debate
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 833-835 (3 pages)

Journal (Volume, Issue Number)

Kidney International (Volume 103, Issue 5)

Publication milestones

  • Published - 05/2023

Publication status

Published - 05/2023

ISSN

0085-2538

Publication IDs

  • Scopus: 85152141808
  • PubMed: 37085255

Publication metrics

Metrics

Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
1
Citation count
1

Funding Details

This work was supported by the National Natural Science Foundation of China ( 82270734 and 82090024 ), the National Key Research and Development Program of China ( 2020YFC2005004 ), and the Key R&D Projects of Hunan Province ( 2021SK2055 ).
FundersFunding numbers
Key R&D Projects of Hunan Province
2021SK2055
NSFC
82090024, 82270734
NKRDPC
2020YFC2005004